Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants

[MEDPAGE TODAY]( Oncology Update Tuesday, August 27, 2024 [Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants]( [Adding MRI to DBT Screening in Women With Dense Breasts May Avert More Cancer Deaths]( [FDA Could Soon Limit Use of Only Drug for COVID Prevention]( [PERSPECTIVES]( [Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care]( [PERSPECTIVES]( [The Global Fight Against Infection-Driven Cancers]( ADVERTISEMENT Exclusives & Features [Will MDMA Rejection Cast a Chill on Psychedelic Research?]( [What Do We Know About Kamala Harris' Medical History?]( [Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board.]( Ewing sarcoma (ES) is a malignant tumor of bone and soft tissue that most often occurs in children, adolescents, and young adults. Debate and controversy remain in the management of... [READ MORE]( [Long-term intraperitoneal access with description of a new access catheter.]( BACKGROUND AND OBJECTIVES: Intraperitoneal chemotherapy can be administered as a single dose associated with hyperthermia (HIPEC) or in successive doses under normothermic conditions, such as early... [READ MORE]( [Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma.]( BACKGROUND: To explore the most effective adjuvant chemotherapy regimen for malignant peritoneal mesothelioma (MPM) through patient derived tumor-like cell clusters (PTC) drug sensitivity... [READ MORE]( [Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma.]( PURPOSE: It is unknown to what extent 10-year overall survival of radical nephrectomy treated intermediate/high-risk non-metastatic clear cell renal carcinoma patients differs from age- and... [READ MORE]( [Emergency department diagnosis and management of acute pulmonary embolism.]( Despite advances in clinical decision support, the diagnosis, prognostic risk stratification, treatment and disposition of emergency department patients with pulmonary embolism remain challenging.... [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-08-27&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011